Alectinib

Alectinib is a medication used to treat a type of lung cancer called non-small cell lung cancer that has specific genetic changes. It works by targeting and blocking abnormal proteins produced by cancer cells, which helps slow or stop their growth. This targeted approach often results in fewer side effects compared to traditional chemotherapy. Alectinib is taken orally as a pill and is typically prescribed for patients whose cancer has a genetic mutation called ALK-positive. It has improved outcomes and quality of life for many patients with this condition.